FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely biopharmaceutics, and may be used for making vaccines. For this purpose, the composition stabilising a polysaccharide-protein conjugate, contains: (1) buffer saline with said buffer having pKa approximately 3.5 to about 7.5, (2) polysorbate 80 in the final concentration of 0.001% to 0.05 wt/vol % of the composition, and (3) one or more polysaccharide-protein conjugates containing one or more pneumococcal polysaccharides. The group of inventions also relates to a syringe filled with the above composition.
EFFECT: use of this composition can improve the stability of the immunogenic compositions, and inhibit deposition thereof.
28 cl, 8 tbl, 7 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MULTIVALENT COMPOSITION OF PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE | 2007 |
|
RU2493870C2 |
MULTIVALENT COMPOSITION OF PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE | 2007 |
|
RU2484846C2 |
POLYVALENT COMPOSITION CONTAINING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | 2013 |
|
RU2605834C2 |
MULTIVALENT COMPOSITION BASED ON PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | 2013 |
|
RU2606152C1 |
MULTIVALENT COMPOSITION OF PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE | 2013 |
|
RU2613148C2 |
COMPOSITION OF PNEUMOCOCCAL CONJUGATE VACCINE | 2018 |
|
RU2789546C2 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
STREPTOCOCCUS PNEUMONIAE CAPSULE POLYSACCHARIDE AND ITS IMMUNOGENIC CONJUGATE | 2019 |
|
RU2803122C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND APPLICATION THEREOF | 2021 |
|
RU2774075C1 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
Authors
Dates
2013-05-27—Published
2007-04-19—Filed